Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3374PDF: 1374HTML: 2677 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1431PDF: 834HTML: 3124 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2852PDF: 1107HTML: 126 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1586PDF: 500MP4: 429Html: 201 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2018PDF: 825HTML: 228 -
-
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1266PDF: 857HTML: 82 -
-
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1720PDF: 742HTML: 236 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2361PDF: 977HTML: 11139 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1325PDF: 478HTML: 18617Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
868PDF: 490HTML: 1310 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7114PDF: 4008HTML: 24900 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4448PDF: 1735HTML: 1062 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2237PDF: 1179HTML: 2596Study of serum haptoglobin level in thalassemia: 354Figures: 185 -
-
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
2005PDF: 1017HTML: 432 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2144PDF: 674HTML: 293 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5401PDF: 2809HTML: 30245Antinori Tables 1,2,3: 362 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1826PDF: 718HTML: 409 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1744PDF: 636HTML: 1522Figure 1: MRI demonstrating Aspergillus synovitis: 190Figure 2:MRI demonstrating Aspergillus synovitis: 196 -
-
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1677PDF: 1017HTML: 371 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3560PDF: 1007HTML: 442Table 1.: 235 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2135PDF: 1921HTML: 355 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4314PDF: 1536HTML: 460 -
WHAT ARE FUNGAL INFECTIONS?
4258PDF: 2427HTML: 27640de Pauw: 245







